Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
Chong Li,1,2 Yixin Wang,3 Xiaolin Zhang,1 Li Deng,1 Yan Zhang,1 Zhangbao Chen1 1Key Laboratory on Luminescence and Real-Time Analysis, Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chongqing, People's Republic of China; 2School of Pharmacy, Key Laborato...
Guardado en:
Autores principales: | Li C, Wang Y, Zhang X, Deng L, Zhang Y, Chen Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c404150c81c7451c9c66e4ccdcc7d117 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song Z, et al.
Publicado: (2017) -
An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery
por: Ding Y, et al.
Publicado: (2015) -
Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
por: Chen Z, et al.
Publicado: (2012) -
Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu L, et al.
Publicado: (2018) -
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
por: Kebebe D, et al.
Publicado: (2018)